GGrantIndex
Sort

141,003 grants matching cytokine

Insights into a multi-hit process in the development of necrotizing enterocolitis

$658,795
Xiao-Di Tan · University Of Illinois At Chicago · R01 · FY2023 · DK

Development of a topical malaria vaccine.

$658,790
Elizabeth H Nardin · New York University School Of Medicine · R01 · FY2017 · AI

Role of CASP-11 in SARS-CoV-2-induced lung pathologies and long-term immune protection

$658,785
Prosper N Boyaka · Ohio State University · P01 · FY2024 · AI

The impact of T cell selection on vaccine durability

$658,748
Laura Su · University Of Pennsylvania · R01 · FY2021 · AI

Effector and regulatory T cell responses and protection from clinical malaria

$658,721
Margaret E Feeney · University Of California, San Francisco · R01 · FY2017 · AI

The Neuroimmunology of Depression in Women Living With HIV

$658,719
Vilma Gabbay · University Of Miami School Of Medicine · R01 · FY2025 · MH

Circadian Rhythm and Lifespan

$658,714
Joseph S Takahashi · Ut Southwestern Medical Center · R01 · FY2025 · AG

Exposure and biological response biomarkers of cigarette smoke

$658,708
Ian Alexander Blair · University Of Pennsylvania · U01 · FY2009 · ES

Impact of Malnutrition on HIV Treatment Failure in Resource-Limited Settings

$658,685
Amita Gupta · Johns Hopkins University · R01 · FY2010 · AI

Mechanisms of Right Ventricular Dysfunction in PAH

$658,659
Paul M Hassoun · Johns Hopkins University · R01 · FY2014 · HL

Biophysical and functional coupling of protein condensates to ordered lipid domains in T-cells

$658,657
Ilya Levental · University Of Virginia · R01 · FY2025 · AI

Nanoparticles based mRNA delivery for treatment of cystic fibrosis

$658,627
Gaurav Sahay · Oregon State University · R01 · FY2021 · HL

Nanoparticles based mRNA delivery for treatment of cystic fibrosis

$658,627
Gaurav Sahay · Oregon State University · R01 · FY2022 · HL

Nanoparticles based mRNA delivery for treatment of cystic fibrosis

$658,627
Gaurav Sahay · Oregon State University · R01 · FY2023 · HL

LRRK2 and inflammasome pathway in Parkinson's disease

$658,627
Wanli W Smith · Johns Hopkins University · R01 · FY2022 · NS

Novel targeted therapy for treating Ovarian Cancer

$658,621
Ratna K Vadlamudi · University Of Texas Hlth Science Center · R01 · FY2025 · CA

Defining molecular pathways triggered by IL-10 and TGFb that drive HIV integration and persistence in Tfh cells in lymph nodes

$658,579
Susan Pereira Ribeiro · Emory University · R01 · FY2025 · AI

A prospective study of CFS following infectious mononucleosis in college students

$658,576
Ben Z. Katz · Lurie Children'S Hospital Of Chicago · R01 · FY2017 · AI

Host factors and viral determinants mediating flavivirus NS1 tissue-specific endothelial dysfunction and vascular leak

$658,551
Eva Harris · University Of California Berkeley · R01 · FY2024 · AI

Deciphering the role of junctional adhesion molecule-A in neutrophil-driven inflammatory response in Alzheimer disease

$658,532
Anuska V Andjelkovic-Zochowska · University Of Michigan At Ann Arbor · R01 · FY2023 · AG

Comprehensive Characterization of Glycosylation Alterations in Alzheimer’s Disease

$658,515
Angela M Zivkovic · University Of California At Davis · R01 · FY2018 · AG

T-Cell Vaccine-A Clinical Trail for Progressive MS

$658,481
University Of Southern California · R01 · FY2004 · NS

Identifying therapeutic pathways targeting medulloblastoma-immune cell interactions

$658,459
Ernest Fraenkel · Massachusetts Institute Of Technology · U01 · FY2022 · CA

Genetic and Small Molecule Regulation of Mechanisms of Crohn’s Disease Stricture Formation

$658,456
Lee Armistead Denson · Cincinnati Childrens Hosp Med Ctr · R01 · FY2025 · DK

Ultrasmall particle-based solutions for inducing ferroptosis and improving anti-tumor immune responses in cancer

$658,454
Michelle S Bradbury · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA